InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: TampaTradr post# 271080

Sunday, 08/28/2016 8:14:26 PM

Sunday, August 28, 2016 8:14:26 PM

Post# of 345681

Bio, THEY ALREADY STATED that shelf shares will not be reverse split.

My post included the direct quote from the proxy that stated this.

No amount of letters will change this.



Tampa, I think you fail to understand the terms "outstanding shares" vs "authorized shares"

No where in the proxy does it say that "authorized shares" will be reverse split, as all outstanding shares would be (IF the BOD takes action for a RS).

It spells it out very clearly, the authorized shares are not being split/reduced at all. It is telling you your common shares are being reduced, NOT that the authorized shares are being reduced.

------------------------------------

..taken from page 13 of the SEC filing

Although the Reverse Split will not have any dilutive effect on our stockholders, the proportion of shares owned by our stockholders relative to the number of shares authorized for issuance will decrease. As a result, the additional authorized shares of common stock will be available for issuance at such times and for such purposes as the Board of Directors may deem advisable without further action by our stockholders, except as required by applicable laws and regulations. We do not have any present plan or intention to issue the additional shares of authorized but unissued common stock that would become available as a result of the proposed Reverse Split.

http://ir.peregrineinc.com/secfiling.cfm?filingID=1019687-16-7374&CIK=704562


"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News